rdc-imp

IMPURITY

RD&C developed a novel systemic analysis concept for impurity profiling in pharmaceutical drug process development and impurity related deviation management at development stage or in routine drug manufacturing.

rdc-synergy

SYNERGY

RD&C together with ICIQ develops novel co-crystals and crystalline multi-component structures formed by two or more molecules to generate synergistic efficacy based on improved bioavailability, by increased solubility, or decreased plasma protein binding of current treatment options pursuing the concept of polypharmacology, the treatment of diseases by modulating more than one target.

rdc-concept

CONCEPTS

RD&C combines in depth scientific knowledge of various research disciplines to coordinate and guide innovative concepts for new drug candidates. Regulatory compliant drug development documentation and expert dossiers are provided on sound scientific and regulatory experience.

News

  • Prof. Holzgrabe and Dr. Buschmann published in DAZ

    Prof. Ulrike Holzgrabe (University Wuerzburg) and Helmut Buschmann (RD&C) published a recent article in DAZ on Remifentanil

    - Helmut Buschmann
  • RD&C was invited as speakers for 2-days-workshop “Stability by Design”

    Concept Heidelberg/ECA invited Helmut Buschmann and Norbert Handler to give talks for the workshop "Stability by Design". The 2-day course was held in Berlin 4. and 5. April with 35 participants.

    - RD&C team
  • SOLID STATE REACTION PLATFORM

    The method could be used for prediction of stability, polymorph changes, shelf-life, degradations in solid environment as well as development tool for solid formulations. The service is offered to customers, but is also open for out-licensing.

    - RD&C Team
  • RD&C GmbH registered the Austrian trade „CONSULTING ENGINEER FOR PHARMACY (Ingenieurbüro für Pharmazie)”.

    This accredited chartered engineer status warrants fitness for combining a broad technical background with an objective view, directed towards protecting the clients’ interests and ensuring superior performance at the lowest commensurate cost. Chartered engineer status ensures quality, employability and professional recognition.

    - Dr. Norbert Handler
  • Dr. Norbert HANDLER is announced “general authorized and certified expert for pharamceutical chemistry” at the Trade Court of Vienna

    The expert status is announced for 5 years comprises the fields pharmaceutical chemistry, pharmaceutical products and cosmetics.

    - RD&C team
  • RD&C is co-editor for Elsevier’s COMPREHENSIVE MEDICINAL CHEMISTRY III

    RD&C team was responsible for section 2 "Drug Discovery Technologies". The book is in press and will be published in June 17.

    - RD&C team